Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Colletti

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 10, 2010
GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109aJason E Imbriglio, Sookhee Chang, Rui Liang, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2009
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitorsHong C Shen, Fa-Xiang Ding, Siyi Wang, et al.
Journal of Medicinal Chemistry|May 19, 2009
Discovery of the development candidate N-tert-butyl nodulisporamide: a safe and efficacious once monthly oral agent for the control of fleas and ticks on companion animalsPeter T Meinke, Steven L Colletti, Michael H Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2012
Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitorsZhicai Wu, Cangming Yang, Thomas H Graham, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2007
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic propertiesJun Wang, Srinivas Kodali, Sang Ho Lee, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2012
Discovery of a new class of potent prolylcarboxypeptidase inhibitors derived from alanineZhicai Wu, Cangming Yang, Yusheng Xiong, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitorsHong C Shen, Fa-Xiang Ding, Changyou Zhou, et al.
Journal of Medicinal Chemistry|March 25, 2009
Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in ratsHong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.
Bioconjugate Chemistry|January 14, 2014
Improving the in vivo therapeutic index of siRNA polymer conjugates through increasing pH responsivenessErin N Guidry, Julie Farand, Arash Soheili, et al.
Journal of Medicinal Chemistry|August 4, 2009
Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagementHong C Shen, Fa-Xiang Ding, Siyi Wang, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|July 10, 2010
GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109aJason E Imbriglio, Sookhee Chang, Rui Liang, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2009
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitorsHong C Shen, Fa-Xiang Ding, Siyi Wang, et al.
Journal of Medicinal Chemistry|May 19, 2009
Discovery of the development candidate N-tert-butyl nodulisporamide: a safe and efficacious once monthly oral agent for the control of fleas and ticks on companion animalsPeter T Meinke, Steven L Colletti, Michael H Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2012
Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitorsZhicai Wu, Cangming Yang, Thomas H Graham, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2007
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic propertiesJun Wang, Srinivas Kodali, Sang Ho Lee, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2012
Discovery of a new class of potent prolylcarboxypeptidase inhibitors derived from alanineZhicai Wu, Cangming Yang, Yusheng Xiong, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitorsHong C Shen, Fa-Xiang Ding, Changyou Zhou, et al.
Journal of Medicinal Chemistry|March 25, 2009
Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in ratsHong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.
Bioconjugate Chemistry|January 14, 2014
Improving the in vivo therapeutic index of siRNA polymer conjugates through increasing pH responsivenessErin N Guidry, Julie Farand, Arash Soheili, et al.
Journal of Medicinal Chemistry|August 4, 2009
Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagementHong C Shen, Fa-Xiang Ding, Siyi Wang, et al.
Pageof 8